AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
May 15--CORIXA STOCK INCREASES JUST BEFORE EARNINGS RESULTS: Corixa stock rose $1.25 yesterday, or 25 percent, to $6.25 ahead of today's scheduled release of first-quarter earnings.
The Seattle biotech company is holding a conference call this morning. It is expected to discuss the status of Bexxar, its leading drug candidate for non-Hodgkin's lymphoma, which has been delayed by the Food and Drug Administration.
ASHFORD, AMAZON DEALINGS MIGHT BE HEADED FOR COURT: Ashford.com's accounting and disclosures for a marketing agreement with Amazon.com may be the subject of a federal court-enforcement proceeding, according to a regulatory filing.